Canada - English - Health Canada

proval pharma division of servier canada inc - gliclazide - tablet - 80mg - gliclazide 80mg - sulfonylureas

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaforte (malaysia) sdn. bhd. - gliclazide -

Ireland - English - HPRA (Health Products Regulatory Authority)

bristol laboratories limited - gliclazide - prolonged-release tablet - 30 milligram(s) - sulfonamides, urea derivatives; gliclazide

Ireland - English - HPRA (Health Products Regulatory Authority)

brillpharma (ireland) limited - gliclazide - prolonged-release tablet - 30 milligram(s) - sulfonamides, urea derivatives; gliclazide

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - gliclazide -

Philippines - English - FDA (Food And Drug Administration)

vitalink health products inc - gliclazide - tablet, modified release - 80mg

Philippines - English - FDA (Food And Drug Administration)

lloyd laboratories, inc. - gliclazide - tablet, modified release - 80mg

Philippines - English - FDA (Food And Drug Administration)

buenar laboratories inc. - gliclazide - tablet, modified release - 80mg

Philippines - English - FDA (Food And Drug Administration)

lloyd laboratories, inc. - gliclazide - modified-release tablet - 80mg

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: mannitol; hypromellose; lactose monohydrate; silicon dioxide; magnesium stearate; sodium acetate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.